Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.

PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3... By Nate Raymond (NSE:RYMD) (Reuters) - Pfizer (NYSE:PFE) has resolved a lawsuit by ...

While Pfizer Ltd had reported Rs179 crore In the corresponding quarter of the previous fiscal, or March quarter of FY24, the net profit in the March 2025 quarter saw a sharp jump to ₹331 crore.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and ...

Q4 results today: PGCIL, DLF, Pfizer, New India Assurance ... with a positive bias is likely to persist for the Indian stock market, supported by easing geopolitical tensions, progress on trade ...